Author

Sarvesh Kumar

Primary ORCID profile (0009-0004-2513-8126 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Sarvesh KumariD1 paper · Aalto University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Ananda Chowdhury· 1 shared Daoud Meerzaman· 1 shared David PeeneyiD· 1 shared Joshua Rich· 1 shared Sadeechya GurungiD· 1 shared Sandra M. Jensen· 1 shared Sasha Coates-Park· 1 shared Tej Pratap Singh· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ananda Chowdhury

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivDec 29, 2023

Timp2 loss-of-function mutation and TIMP2 treatment in murine model of NSCLC: modulation of immunosuppression and oncogenic signaling

David Peeney, Sarvesh Kumar, Tej Pratap Singh…·William G. Stetler-Stevenson

TIMP2 treatment compensates for TIMP2 mutation to reveal immunomodulatory and oncogene regulation that inhibits tumor growth and metastatic niche formation.

DOI 10.1016/j.tranon.2025.102309

mousebulk RNA-seq

𝕏 PostBluesky